LIPPMAN EVAN

PrivateCIK: 2062834
Location

PETACH TIKVA, L3

LIPPMAN EVAN (EVP, Business Development) sold 48.5% of their position (41.66K shares) of TEVA PHARMACEUTICAL INDUSTRIES LTD on the open market

Open‑market sale worth $1.48M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 2 sales
InsiderLIPPMAN EVANCIK 2062834
→
Officer· EVP, Business Development
Since Mar 2026
-41.66K
Net shares
Net seller
$1.48M
Total sold
2
Open market trades
0B · 2S
6
Total transactions
85.85K acquired · 127.51K disposed
Non-Derivative Transactions4

Ordinary Shares

Direct
M · Option Exercise

Shares

+11.84K

Price / share

—

Trade value

—

% of position

New position
5/14/2026
0.00→11.84K

Ordinary Shares

Direct
S · Sale

Shares

−5.75K

Price / share

$35.58

Trade value

$204.47K

% of position

48.5%
5/14/2026
11.84K→6.09K

Ordinary Shares

Direct
M · Option Exercise

Shares

+74.01K

Price / share

—

Trade value

—

% of position

1214.2%
5/14/2026
6.09K→80.10K

Ordinary Shares

Direct
S · Sale

Shares

−35.91K

Price / share

$35.58

Trade value

$1.28M

% of position

44.8%
5/14/2026
80.10K→44.19K
Total

Net shares

+44.19K

Net value

-$1.48M

Derivative Transactions2

Restricted Share Units

Direct
M · Option Exercise
Converts to

Ordinary Shares

11.84K shares

Shares

−11.84K

Strike price

Held after

35.52K

Exercisable

—

5/14/2026

Restricted Share Units

Direct
M · Option Exercise
Converts to

Ordinary Shares

74.01K shares

Shares

−74.01K

Strike price

Held after

74.01K

Exercisable

—

5/14/2026
LIPPMAN EVAN — Insider Transaction (Form 4) Filed May 18, 2026 | Finecho